• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEDTRONIC HEART VALVES DIVISION ENVEO R DELIVERY SYSTEM; AORTIC VALVE, PROSTHESIS, PERCUTANEOUSLY DELIVERED

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEDTRONIC HEART VALVES DIVISION ENVEO R DELIVERY SYSTEM; AORTIC VALVE, PROSTHESIS, PERCUTANEOUSLY DELIVERED Back to Search Results
Model Number ENVEOR-N-US
Medical Device Problem Codes Positioning Failure (1158); Detachment of Device or Device Component (2907)
Health Effect - Clinical Code Calcium Deposits/Calcification (1758)
Date of Event 06/27/2017
Type of Reportable Event Malfunction
Additional Manufacturer Narrative
The product was not returned, therefore no product analysis can be performed.Without return of the product, a conclusive cause cannot be determined.The reported description is consistent with capsule damage/separation events when the compressive forces initiate capsule damage which can then result in a fracture in the capsule frame, and subsequently upon retraction, the capsule separates.Without angiographic record for review, it was unknown when the reported capsule damage occurred; it is possible that the capsule damage occurred after/during removal from the patient.A device history record (dhr) review was performed on the delivery catheter system (dcs) and there were no correlations / issues identified regarding manufacturing.The device was manufactured per approved and released manufacturing processes and the device met all applicable manufacturing specifications prior to release for distribution.If information is provided in the future, a supplemental report will be issued.
 
Event or Problem Description
Medtronic received information that during the implant of a transcatheter bioprosthetic valve, and audible ¿pop¿ occurred during deployment of the valve.It was noted that at that point the end cap to the delivery catheter system (dcs) did not separate.The valve was attempted to be deployed by turning the deployment handle, but the dcs would not deploy the valve.The system was removed from the patient without issue and the capsule separated from the catheter.It was reported that calcification was encountered in the common lilacs and the aorta.No adverse patient effects were reported.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ENVEO R DELIVERY SYSTEM
Common Device Name
AORTIC VALVE, PROSTHESIS, PERCUTANEOUSLY DELIVERED
Manufacturer (Section D)
MEDTRONIC HEART VALVES DIVISION
1851 e deere ave
santa ana CA 92705
MDR Report Key7271175
Report Number2025587-2018-00380
Device Sequence Number1847395
Product Code NPT
UDI-Device Identifier00643169956193
UDI-Public00643169956193
Combination Product (Y/N)N
Initial Reporter StateMN
Initial Reporter CountryUS
PMA/510(K) Number
P130021
Number of Events Summarized1
Summary Report (Y/N)N
Reporter Type Manufacturer
Report Source company representative,health
Initial Reporter Occupation Physician
Type of Report Initial
Report Date (Section B) 02/14/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Expiration Date04/26/2018
Device Model NumberENVEOR-N-US
Device Catalogue NumberENVEOR-N-US
Device Lot Number0008602084
Was Device Available for Evaluation? No
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 01/22/2018
Initial Report FDA Received Date02/14/2018
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Patient Sequence Number1
-
-